Back to top

Phio Pharmaceuticals Announces Pathology Results for Four of Five Patients in Fourth Cohort | ...

Phio Pharmaceuticals Announces Pathology Results for Four of Five Patients in Fourth Cohort | PHIO Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Phio Pharmaceuticals Corp. (PHIO)